This HTML5 document contains 143 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n13http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n9https://scigraph.springernature.com/pub.10.1186/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q41154385
rdf:type
wikibase:Item
schema:description
scientific article published on 12 September 2017 artikulong pang-agham научна статия مقالة علمية نشرت في 12 سبتمبر 2017 2017年論文 article scientifique scientific article published on 12 September 2017 2017년 논문 videnskabelig artikel vedecký článok наукова стаття, опублікована у вересні 2017 2017年論文 scientific article published on 12 September 2017 artigo científico บทความทางวิทยาศาสตร์ vetenskaplig artikel 2017年論文 Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia. 2017年论文 articolo scientifico artikull shkencor научни чланак 2017 թվականի սեպտեմբերի 12-ին հրատարակված գիտական հոդված teaduslik artikkel 2017年论文 2017年の論文 wetenschappelijk artikel artykuł naukowy tudományos cikk artigo científico vitskapeleg artikkel vědecký článek artículo científico publicado en 2017 scienca artikolo επιστημονικό άρθρο 2017年論文 2017年论文 artigo científico научная статья wissenschaftlicher Artikel ১২ সেপ্টেম্বর ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ מאמר מדעי artikel ilmiah 2017年论文 articol științific 2017年论文 tieteellinen artikkeli სამეცნიერო სტატია naučni članak мақолаи илмӣ vitenskapelig artikkel научни чланак 2017 nî lūn-bûn article científic article scientific bài báo khoa học bilimsel makale 2017年論文 2017年论文
p:P577
wds:Q41154385-2099FD13-75E6-4FED-BAA8-ED37F5F86D91
wdt:P577
2017-09-12T00:00:00Z
p:P2888
wds:Q41154385-B7E86330-E923-4495-8E54-33F15740EE60
wdt:P2888
n9:s12894-017-0275-6
p:P2860
wds:Q41154385-86A1FCD9-79ED-49DD-8D5A-47BA622CA05F wds:Q41154385-30D7914D-2BF9-4810-B010-B8061BB72C1F wds:Q41154385-38AD7E34-76B4-45CF-8905-2187C51FC697 wds:Q41154385-40C6FCA5-773B-4E90-8369-A26845C2370B wds:Q41154385-0A0B372F-125B-44DF-8B4D-99C9AE9C1D4A wds:Q41154385-115734C1-6728-4C2F-A738-E57FD2C2AD30 wds:Q41154385-178AE0D3-D419-474B-959D-6A776869F217 wds:Q41154385-0279D04D-4BC7-442B-A3D5-50509737DB73 wds:Q41154385-097DDD5D-139A-4590-BC41-6272E6FBEECB wds:Q41154385-F95DECDB-3586-464F-9FD3-7F69A9FEC330 wds:Q41154385-C49E0A8F-EEA7-4959-83AA-CD4089021558 wds:Q41154385-E7111A10-2A56-4CEE-B483-70E371246BAD wds:Q41154385-BD04875C-BD92-41AD-ABBA-CFBF21E204FD wds:Q41154385-BE78017A-A4C5-422D-A85E-397D4EC47660 wds:Q41154385-BF858D31-AC6D-40BC-9E74-AF3A46158570 wds:Q41154385-C44CE374-4267-4BFB-A31D-59CAE6AF2C1C wds:Q41154385-A11DB8F5-93FE-4004-8F09-661B7668B4A0 wds:Q41154385-A85AEEB9-0E27-4CF1-88AC-F7DBEFEBF265 wds:Q41154385-9373240F-FF9A-4273-877F-70554A937FD5 wds:Q41154385-9B48D9FA-670B-485B-859A-3461C05D56E1 wds:Q41154385-9E00FFD6-4C28-4342-94A6-14D48CEA5FAB wds:Q41154385-A0D86E9B-BD53-49E9-A8E4-AF71A1AA7DA0 wds:Q41154385-713AFE25-7A21-4FEC-BB5F-A6CF653B25C7
wdt:P2860
wd:Q35089850 wd:Q46527182 wd:Q83178931 wd:Q83809760 wd:Q83185153 wd:Q81571965 wd:Q43490308 wd:Q46221920 wd:Q46085326 wd:Q44498018 wd:Q37639586 wd:Q48277156 wd:Q83962270 wd:Q33579038 wd:Q40695489 wd:Q29547376 wd:Q37656444 wd:Q46569147 wd:Q30863541 wd:Q30593090 wd:Q38125007 wd:Q37331049 wd:Q37865811
p:P2093
wds:Q41154385-00DC370F-56DE-4A2A-A67E-14D7060D0D01 wds:Q41154385-76633E80-04AA-4890-9B00-1DA7FB850B74 wds:Q41154385-B99C06B0-5740-4192-9BEB-1B8B2D3AB4F1
wdt:P2093
Ana Mª Mora Marta Hernández Ruth Navarro-Artieda
rdfs:label
Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia
skos:prefLabel
Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia
schema:name
Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia
p:P50
wds:Q41154385-4D159344-7269-46E5-8716-CFBA94265DDA
wdt:P50
wd:Q100386310
p:P1476
wds:Q41154385-0CBB3DF5-522B-4D15-91D2-7FDA9108EA58
wdt:P1476
Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia
p:P304
wds:Q41154385-F717BD41-B571-48A1-9F07-AA7B751F127B
wdt:P304
83
p:P31
wds:Q41154385-5859E32E-D1A9-4783-9885-214D253C4F12
wdt:P31
wd:Q13442814
p:P698
wds:Q41154385-D67976E2-CD65-4195-93A0-90E61F3310AF
wdtn:P698
n11:28899370
wdt:P698
28899370
p:P1433
wds:Q41154385-0681C33E-EB10-4110-9FF6-532C7870F6FB
wdt:P1433
wd:Q15752925
p:P433
wds:Q41154385-CE97BBBC-3EDA-4989-A6CB-54C5A4EA665D
p:P478
wds:Q41154385-4A1B903C-C790-4057-B83B-E191FD148A74
wdt:P433
1
wdt:P478
17
p:P356
wds:Q41154385-63E4C3AB-2917-4E7C-8662-9029C59F62E5
wdtn:P356
n13:S12894-017-0275-6
wdt:P356
10.1186/S12894-017-0275-6
p:P6179
wds:Q41154385-05E049C8-6CE7-4871-AA10-4F33021A4017
wdt:P6179
1091612642
p:P932
wds:Q41154385-638362FB-CEF5-46C5-9E56-F7FDEB49E840
wdt:P932
5596857